![]() |
8th International AIDS ConferenceAmsterdam, Netherlands — July 19-24, 1992 |
Int Conf AIDS 1992 Jul 19-24; 8:We57 (abstract no. WeC 1066)
Siby T, Thior I, Marlink R, Diaw PA, Traore I, Hellinger J, Ndoye I, Mboup S, Kanki P, Essex M; Universite Cheikh Anta Diop, Dakar, Senegal.
OBJECTIVES: To compare the clinical and immunological evolution HIV-2 vs. HIV-1 infection.
METHODS: Since 1987, asymptomatic female sex workers visiting the National STD Clinics in Senegal have been enrolled in a prospective study including clinical follow-up, T-cell subsetting in the latter 2 years of study, and tuberculin skin testing.
RESULTS: With 353 women enrolled in the study, complete follow-up rate is 80% and active follow-up has produced vital status information on another 10%. Clinical outcome is summarized utilizing person-years observed (PYO) and incidence rates (IR). Dual reactive individuals are currently excluded. TABULAR DATA, SEE ABSTRACT VOLUME. Rate ratios of HIV-1:HIV-2 were significantly greater than 1 for AIDS, CDC IV and death when incidence rates of disease outcomes were compared. Immunologic parameters, abnormal T-cell subsets and skin test anergy were intermediate for the HIV-2+ women when compared to seronegative and HIV-1+ women, although enrollment values are not available prior to 1989.
CONCLUSIONS: For the first time, significant differences can be shown in actual disease progression rates between HIV-1 and HIV-2. Seroincident cases need to be accumulated within this cohort to more precisely determine disease outcome rate differences.
Copyright © 1992 - International AIDS Society (IAS). Reproduction of this abstract (other than one copy for personal reference) must be cleared through the IAS.